TrialInternational journal of hematology2013

A randomized dose-escalation study to assess the safety, tolerability, and pharmacokinetics of ruxolitinib (INC424) in healthy Japanese volunteers.

Yoichiro Ogama et al.PubMed ↗Publisher ↗

No numbers read from the abstract.